Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Gastrointestinal 87 Breast 67 Thoracic 53 Genitourinary 47 Gynecologic 31 Head & Neck 30 Tumor-Agnostic 22 Dermatologic 22 CNS 20 Other hematologic neoplasm 19 Lymphoid 17 Myeloid 15 Sarcoma 14 Plasma cell 9 Other solid neoplasm 8 Endocrine 7 Other 5 Other neoplasm 3 Classical hematology 3 NET 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 6 Magnetic Resonance Spectroscopy 3 Data Collection 3 telotristat ethyl 2 surufatinib 2 Somatostatin 2 Positron-Emission Tomography 2 Everolimus 2 Drug Therapy 2 Biopsy 2 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Quality of Life 1 Plastic Surgery Procedures 1 Phlebotomy 1 Patient Reported Outcome Measures 1 Octreotide 1 Molecular Diagnostic Techniques 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Blood Specimen Collection × NET × Clear all

NCT06430021 2026-05-22

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡